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Since the introduction of percutaneous tratiuminal coronary 
angioplasty into clinical practice by Andreas Gtuentzig in 1977 
(I ,2), the efficacy of this technique in the treatment of coronary 
artery disease, both native and vein graft vessels, has cleariy 
become established (L6), with continuing grawth such that 
the number of angioplasties performed per year equals that of 
coronary artery bypass operations. The immediate and medii- 
term outcomes are well dexrii, with the problems of abrupt 
closure and restenosis antinuing to elude attempts to reduce 
U Am Gd Gdid 1~27:1669-77) 
their frequency (7-10). Knowkdge of tbe long-tena outoome 
of coronary ang&L&y continues to accumulate Over time 
(11). Recently, King and schlumpf (12) reported on the 
IO-year follow-up of Gruentzig% tkst 169 patients, with an 
overall #year survival rate of 89.5%. 
In tbe present report we descrk the IO-year sutvkal and 
di events of tbe firs2 856 patients treated by angiopkty at 
the Thoraxcenter. Rotterdam in the years 1980 to 19gS. 
M&beads 
PWhts. Between September 1980 and Decemkr 1!X6, 
pe--~~~attempted 
in 856 consecutive patients at tbe ‘fkoraxcenter, Rottez- 
,darn.Patient&aracteristksaredi@ayedinTabk1.The 
. . . ltdmonforaogiopkdyivasstabJe 
~anginain323.acuternyomdd~in76and . . 
uWatmnsin6.Allpatientsrveretreatedwitbaannbi- 
nationofbeta-denergkandcakium~lbiodiingabentf 
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T&e 1. C!mical Characteristics of 856 Patients Who Underwent 
coron3ry Angioplacty During 1980 to 1985 
Maie 6xJ (79.9r;) 
-age63 56.3 
ms 22-84 
Indii6ott for aagioplacty 
stable angitta JSL (52.77) 
llmtabk angina 323 (37.7%) 
MI 76 (8.9%) 
other 6 (0.7%) 
ReviaaMl 341s33 (&q 
RwiousCABG 7a856 (9X) 
No. of vesefs diseased 
1 517817 (63.3%) 
2 193817 (23.6%) 
3 %1117(11.84) 
Mainnem 11m (1.3%) 
EF ~50% lCW629 (16.5%) 
Data presented are number (5) of patients, unless chemise indited 
CABG = mronaty artery bypass graft surgery EF = ejection fraction; MI = 
myncatdial infarction. 
nitrates and, in patients in unstable condition, intravenous 
heparin. 
Aagiopfasty teehniqoe. At the commencement of the an- 
giopIasty procedure, w) mg of acetyisalicylic acid and 100 mg 
of heparin were administered intravenously, with additional 
bolusesof5Omggivenhourly.Aiiercompletionofthepro- 
cedure, if the stability of the immediate result was in doubt, a 
heparin infusion was commenced to achieve an activated 
partial thromboplastin time of 2.0 to 2.5 times control levels for 
12 to 24 h. AU patients continued to receive both nifediiine (40 
to 60 mg) and acetylsahcylic acid (500 mg) once daily for a 
period of at least 6 months. The method of coronary angio- 
plasty changed in February 1983 when the nonst~rable cath- 
eter system originally described by Gruentzig (2) was replaced 
by steerable balloon systems (13). Pmc&mrl clinhl SACC~S 
was de&d a3 a reduction in the lumen narrowing to <SO% of 
the reference diameter, by visual afsesnmc with no major 
aaoplior~(death,myomrdialinfarction,coronarybypasssur- 
geIyorrepeat~)within24hoftheprocedcre.Evidence 
of myocardial infarction immediately after the procedure was 
defined by a new Q wave or elevation of myocardial enzyme 
levels to more than twice the upper limit of normal, or both. 
Data collection and folioa-op. Procedural details, includ- 
ing com$cations, were recorded at the time of the procedure 
and entered into a dedicated data base. Procedure-related 
events were included in all follow-up analyses. In 1994 all 
patients who survived the hospital period were initially 
checked against the civil registry to establish survival or death. 
This is a reliable and complete source of mortality data in The 
Netherlands. Primary end points considered at follow-up were 
death, nonfatal myocardial infarction, rexxrrent angina pecto- 
ris requiring coronary artery bypass surgery or repeat angio= 
plasty and event-free survival. These data were retrospectively 
obtained from the patient by letter or telephone. from the 
family or from the family doctor and checked against hospital 
records. 
Assessment of late myozardial infarction during the follow- 
up period included a history of prolonged chest pain necessi- 
tating hospital admission and documentation of a myocardial 
infarction by electrocardiographic (ECG) or enzyme criteria. 
Information on bypass surgery and repeat angioplasty was 
obtained from the patient and hospital data bases. Addition- 
ally, surviving patients were asked for information regarding 
symptoms of angina pectoris, graded according to Canadian 
Cardiovascular Society classification (14), any resultant limita- 
tion in activities and current medication. Follow-up data were 
obtain& for all but 19 patients (2.2%), the majority of whom 
had moved abroad. The follow-up period ranged from 0 to 13.3 
years (median 9.6). 
Statistical methods. Patient smvivai curves were con- 
structed according to the method of Kaplan and Meier (15). 
Mean values were calculated for continuous variables and 
absolute and relative frequencies for discrete variables. Differ- 
ences between groups were examined for statistical signifi- 
cance by use of a two-sample t test for continuous variables and 
the &i-square teat for discrete variables; p c: 0.05 was consia- 
ered signiticant. Multivariate logistic regression using a com- 
puter package (BMDP) was performed to identify factors that 
----yy 
Nival rates in 856 patients who mKlerwent eotm 
angioplastyduringtk~i985t01985IWtkn 
beIawgrqh=patkntsatrisk25,5,7.5and1Oyears 
OaAw afterangi~~b=lSE.cAl3G= 
cABGIREprcA cwttaryartery~surge~,MI=iqcar&I 
infarction; REPTCA = repeat c~mnaty aqi@asq. 
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Table Z Symptomatic Status and Antianginal Medication in 630 
Surviving Patients 
ccsanginaclau 
0 334(53%) 
I 65(1@%) 
II I34 (?I%) 
111 T7(lS?) 
Iv 0 
Li?oiiiLm of acwitics (symptomatk paliem) 
lhe 4fjPw 
Mild 198 (6% ) 
severe 47(16%) 
AntiangiMi medicat;on 
NOi-XCXaspicill 254(40%) 
sii lhempy’ W(31ri) 
-theraw 125 a=) 
Trip% *raw 53(8%) 
*Nitrate, beta-bkcker 01 cakium ckamel blocker Data presented are 
number (ok) of patienrs. ccs = Canadian car- klciety. 
were related to long-term survival. A forward- and backward- 
stepping algorithm was used with p < 0.05 to identify the 
variabks remaining as independent ri& factors for long-term 
survival. Baseline characteristics tested were age 260 yea- 
gender, prior myocardial infarction, unstable angina multives- 
sel dii, ejection fradi 40% and procedural failure. 
Elesub. During the years 1980 to 1985,969 consecutive 
coronary angiopiasties were performed in 856 patients. The 
procedurai success rate was 82%. Lung-term fouow-up infor- 
mation was obtained for 837 patients (97.8%). 
!kv+al rud symptoms. Sii-hundred forty-one patients 
(77%) were aliie and 1% dead 8 to 14 years after theii initial 
x@oplasty. One hundred forty-three patients had experienced 
a lnyoeardia &r&n, and 220 (25.7%) had undergorte 
corunary artery bypass surgery, iu 62 (7.2%) as an emergency 
procedure immediately after balloon angiophtsty. Two hun- 
dred twenty-one patients underwent further angiopkty in the 
follow-up period, 81 (9.5%) withic 6 months of the initial 
procedure. Patient survival and event-free survival curves were 
calculated using ranked clinical events and are displayed in 
FE&me 2. Cumulative survival rate for patients who 
undetww~ wronary an- eladcd into those 
<50.50 to 59 and a50 yem old al the lime of 
intewentkm.~Foimat as in Fiire 1. 
Figure 1. The overall 5- and IO-year patient survival rates were 
40% and 78%, respectively. and the IO-year survival rate for 
frxdom from death, myocardiil infarction, bsrpass urgery a~; 
repeat angiopkty wa, 36% &year freedom from cardiac 
events 57%). When the learning curve taken into tonsidcr- 
ation, the survival cuIveswere recalculated comparing the first 
226 patients who underwent coronar) angk#&y with the 
mkiteerah’; bakto~ prior to Mircb 1983, with the 630 sub- 
sequent pa&,ats. The 5 and N-year survkal rates were 
identical, as was the I&year freedsm from events. 
Dclaik of symptomatic status and cardiac mediition were 
obtained for 630 (98%) of the 640 survkors. Angina class, 
degee of limitation in 293 of 2!% patients with angina and 
number of Merent ankmginal medications (nitrates and beta- 
andcakiumcham&bkxkers)aredisp@edinTable2Fii- 
three percent of survkns (334 patients) were symptom free. 
and 40% were taking no antknginal medic&m (254 patients). 
Fedar eardi8cevults.TbecliiicaivariaMes 
age, gender, stability of angina, previous myocadial infarction, 
mukivessel disease. impaired left ventrkuhr fhtiou at the 
timeoftheinderaogiopladyandjIrocedural-were 
testedtoseewhethertheyiutlue~~tcrmoutanDe. 
&. Whenpatientswerecbsifiediutotbree~gnnrps 
(<~years[n=201bMto59years[n=342]aadr60years 
[n = 313j), a dear smvival advantage was found in the two 
younger groups at 5 vears ttr the procedure (Fii 2). 
cm&. smvivalandevent-frersurvkalweretestedforttw 
684menandl72 women.Womenweres@kntlyoldtrthan 
menatthetimeofinitialangioplasty,vithamuraageof60.0 
yearscompaRdwith553yearsinmen@<0.001).Addit& 
allywomenbadsutTeredfewermyocxdiiinfar&nsthan 
men before intewentiun (34.6% and 43.6%, reapechiy). 
Therewerenosign&anttiercncesinthe~rdinica 
vatia~namdy,pnviousbypass~,n~berd=k 
diSSdandkfiVClJtriculariIIlpei~t’IhereWaS~difer- 
enceinmortalityoreventratesduringtbefob+uppriod 
(Fii3).However,surhiugwomendidluwesign~tiy~ 
symptoms(4iCaaginafreevs.569ofmw,p<0.05)and 
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Fiire 3. Cumulative survival and event-free SW 
vital rates for patientc who underwent coronary 
angioplasty during 1980 to 1985 classified according 
to gender. Format and abbreviations as in Figure I. 
took significantly more antianginal medication (70% at least 
one antiangina agent vs 57% of men). 
Sinbiliry ofungine Fcur hundred fifty-one patients under- 
went coronary angioplasty for stable angina, 323 for unstable 
angina and 76 for an acute myocardial infarction. When sur- 
vival curves were calculated for patients with stable and 
unstable angina and compared. there were no differences in 
long-term survival and cardiac event rates (Fig. 4). The two 
groups were similar with respect to other clinical variables. 
There were also no diierellces in symptoms and amount of 
antianginal therapy between the survivors of the two groups at 
the time of follow-up. 
plevious myocardial infior. Of 833 pa:ients with docu- 
mented &ails, 341 had a prevkus myocardiai infarction (23 
patienis unkmmnj. A sign&an; survivai beneM for those 
without a previous myocardial inf: rction was detectable only 9 
years afker the index angioplasty (Fig. 5). 
Mdivessel direme. An&~hsty was performed in 517 pa- 
tients with single-vessel disease, 193 with two-vessel disease, 96 
with three-vessel disease and 11 with mainstem disease (39 not 
recorded). When patients were class&d into two groups- 
those with sings-vessel disease and those with multivessel and 
mainstem disease-and survival curves constructed, a clear 
survival advantage was detectable for those with one-vessel 
disease by 1 year after the intervention, with 84% alive at 10 
years versus 69% of those with multivessel disease (Fig. 6). 
However, there was no difference in survival or cardiac event 
rates when patients who underwent single-lesion (n = 672) and 
multiple-lesion (n = 184) angioplasty were compared. 
L& ~~enentricuiar function Left ventricular ejection fraction 
had been calculated in 629 patients: mean [?SD] 59 z II%> 
range 19% to 86%; ~50% in 525, <50% in 104. Survival and 
event-free survival curves were constructed for these two 
groups (Fig. 7). There was a dear survival advan:age for those 
with ejection fraction rSO%, with &WY0 remaining alive IO 
years after angioplasty compared with 57% of those with 
ejection fraction ~50%. However, event-free survival was 
similar, with less myocardial infarction, coronary artery bypass 
surgery and repeat ~ngioplasty occurring in the follow-up 
period in patients wrtn impaired left ventricular function. 
Proceduml success. Anghplasty was suazssful in 700 pa- 
tients (82%). When these patients were compared with those 
with unsuccessful angioplasty with or without a complication, 
long-term smvival was similar. However, significantly more 
J4CC Vol. 27. No. 7 
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Fii 5. Cumulative survival and event-free sur- 
vival rates for patientr who underwent coronary 
angioplasty during the study period classified ac- 
cording to a positive or negative history for previous 
myocardii infarction. Format and abbrevip~mtls as 
in Figure 1. 
major events occurred in patients with a procedural failure, 
predominantly about the time the angioplasty was performed 
(Fig. 8). 
The 5- and IO-year cumulative survival rates for the various 
subgronps evaluated are shown in Table 3. Univariate analyses 
were used to test the it&em-z of the previous seven clinical 
factors on long,-term survival. The odds ratios (ORs) for these 
variables, with 95% confidence intervals (Cfs), are displayed in 
Fii 9. Multivariate analy+ could he performed for 579 
patients with complete data. Age ~60 years (OR 2.42,95% Cl 
1.62 to 3.&J), ejection fraction <50% (OR 2.22,9X CI 1.33 to 
3.70), multivessel disease (OR 1.60,95% Cl 1.06 to 2.42) and 
a history of previous myocardial infarction (OR 154.95% Cl 
1.00 to 2.37) were found to be independent predictors of a 
diminished long-rerm survival. 
Discussion 
In patient m;inagement an inevitable question is, What is 
the prognosis?. The answer can be given only in the light of 
temporal information gained from similar groups of patients 
treated by similar means in the past. This also holds true for 
the management of coronary artery dii by coronary angio- 
plasty. ReExdless of an cvokving change in patient character- 
istics, procedural indications. technique and expertise, knowl- 
edge of the long-term outcome of early angioplasty practice 
remains an important source of information and guidance for 
contemporary card&g& and patients. 
In the present study, we examined the late clinical outcome 
of the first 856 patients who undetxwxtt attempted angio@asty 
in a single center during the years 1980 to 1985. Our patient 
groupkhuied76whounderwentcoronarya@opktyforan 
evoh-iug acute myocardial infanxion and 156 (18%) in whom 
the procedure was an angiographic failure: thus, this wac an 
intention to treat anairjis. Our finding cf an overall S-year 
survival rate of 90%. although favorable. appears to he kcr 
than prevkmsly reported (Table 4). It is recognized that rbe 
prognusis of p&cuts with single-vessel disease and good 
ventricular function is excellent even w$en managed conser- 
vatively (17). When our patients mre compared with oiher 
studii we found that our patients were older and more likely 
to have multivessel dkease, both factors associated with a 
decreased likelihuod of event-free sutGval(l8-20). We sug- 
gest that the bar&x characterktics of our patients more 
ebsely resemble those of patients encountered in current 
angioplasty practice. ‘fhe KLyear survivat rate of our cohort of 
Pi 6. Cumulative survival and event-free w- 
vivairatesforaUpatients&&iedaccci&gtotk 
prewnceofsingle(1M))ormulti-ldbease 
(>l VD). Format and other abbwviatbm as in 
Ftgure 1. 
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ClEAri 
1 
OEATWW 
‘-.--L 
CABWREPTC 
- - .- 
ATRW 503 ion 449 213 
90 a3 73 $2 
342 234 233 02 
71 59 45 21 
patients was 7@%, and to our knowledge, the only reported 
data for comparisons WC irom Gruenlzig’s first 169 patients in 
whom the Inyear suwivaI was 89.5% (12). His patients were a 
highly selecteci group in whom only proximal, discrete, pre- 
dominantly left anterior dezending artery kskms (73%) were 
treated because of the Emitations of the equipment available at 
the time. Furthermore. his patients were younger and had a 
mean age of 49.8 lean compared with 563 years in our study. 
In our study, 543 patknts were <60 years 016 with a IO-year 
survival rate of 85%. 
Onty 36% of our patients were free from further cardiac 
events 10 years after the index procedure (57% event free at 5 
years), no doubt a result of our more general patient cohort 
(myoeardid infarction in 41%, prior copnary bypass surgery in 
956, multiverse disease h X.7%, imp&cd left ventrkular 
function in 165%). Vii all patients with angiograpbkdly 
unswesU angioplasty early in the study period were re- 
ferred for semiurgent mmnary bypass surgery. This tendency 
decreased as eonfkknce in tbe technique grew, witb an overall 
rate of 7.2% over the 5-year period. Recent data (21) show that 
the emeq?ncy bypass surgery rate is now <I%, and it along 
with an impmved pmeedurai success rate (now >%) are 
most liily ihe most changed factors when our study patients 
Fire 7. Cumulative survival and event-free Uli- 
viva1 rates for the 629 patients with a calculated 
ejection trxtion (EF), classified into those with 
cjecfion fraction 40% and 30%. Format and 
other abbreviations as in Figure 1. 
are compared with those of :he present day because the rates 
of death, myocardial infarction, restencis and repeat interven- 
tion have changed little in the past decade (213). The 
long-t-;-n? outcome of patients undergoing contemporary an- 
gioplasty may therefore be Ir.ore eomparablc to patients in the 
present study with a successful procedure. 
F&JR? survival We tested the dinid factors 
of age, gender, previous myocardial infarction, stabiity of 
angina, multivessel disca~ and left ventricular function to 
asses whether they influenced long-term survival. Although 
coronary angioplasty has been shown to be safe and effective in 
elderly patients with coronary artery disease (B), our data, in 
agreement with others, show signifnxntly reduced long-term 
survivalinpatientsr60yearsoldatthetime,oftheitirst 
angioplasty procedure (24). This result may bc explained by 
the more extensive coronary artery disease, with possibiy less 
complete revascularization, in this group of patients. Addition- 
ally, it is possible that more deaths resulted from other disease 
processes more likely to manifest with advancing years because 
our mortality data included deaths from all causes. 
The finding that men and women have a similar outcome 
after angioplasty in the intermediate term (16JS) has ken 
Fii 8 Cumtive smvival and event-free survival 
latesforaup2~t5dassifiedaaalrdirrgIQvvhetbettbe 
ProcpdureWOSg- or failure. Format and abbre- 
viatiO&aSinFii1. 
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T&k 3. Factors lnffucncina 5- and IO-Year Survival 
Sunid Rate 
SYeal 95% cl IOYa- %%cl pvalue I_- 
owan 90% 87.6-9Uk 78"L 7sIl-81.K 
Ik 
<wYr 95% 918-98x 88% 83.4-9zm 
M-59 yl 93% 90.2~958% 8295 776..8.54% 
s6oyr 84% 79.6~88.2% 67% 614-72H <O,woS 
Male 9% 87.4-92.6s 78% 74.6-81.4% 
Female 91% 86.6-954% l9% ml-85.4?4 0.97 
NopmioarMl 92% 89.4+4.6% 83% 79.4~866% 
RwioasMI 88% fH.4-91.6% lZ% 67.0-R% ~0.005 
-aagina 92% 892-94BI LW% 76.0~84.0% 
uaaaweaagiaa 91% 8lB-942% 16% 71.0-81.0% 0'2 
8i@e-veweIW 93% 90.6-95.4% 82% 78.4-85.6'S 
hf~diseaae 84% 798~882% 69% 63.2-7481 <O:YE 
EF ~50% 91% 8R.4JJ3.6% aI% 162-83.85 
EFaFx? 7% fl.ll-87lw m.2 47.4~66.6% < CJ.@QS 
-- 91% 88B%2% 77% 736-la.4% 
praedursfcailwe 81% 82Jlm Bfnc 73.4-66.6s 0.65 
extendedtotbekmgtermbyourstudy.The10-yearsmvival 
rate was 78% for men and 79% for women, and the event-free 
smvivairatewasidentkalat36%.However,thereareseveraJ 
importantdiRensnusindemographic,cbicaland~ 
graphiccharactefisticsbetweenthextwogroups.fnour5hxly. 
women were sigoihntly 4ider than melt at !b Time of 
ammary aqjo+ty$ a factor found to be so&ted with a 
le6sfavoraMelnI~.rtispossiMetllathadthetetwoglnups 
beenmatchedfor~,womenmaybavehadamorefawrabk 
outiamlethanoleIl.~argurneatis- lrythedevec 
opmentofatmwyarterydkseatalaterageinwomenthan 
menandisrelatedtotheprote&eeffectofestqeo.Other 
imfYmantfactonnotitssessedinourshidyarethe- 
l&ebodofanadverse~factorpmtile(16)andnnaller 
auonalyvessels,!Mkingan~tedtaicallynwre~ 
inwornen.Ourtbdingofsigniticantlym0reanginainswviviq 
wmenthaninmen(59%vk44%)ircuns&entwitbtbe 
fkdiogsofofkeyetal(25),~~reportcdurgiaaia~0f 
~30:~Wofmea4yeasafterthe 
Tbedetrimentalinfluenceofap&ousrnpca&finfarc- 
timallddatedreftventriadarhnpainoeaonoahas 
againheendeaonstrated inthepresent8bldy.However.thrwe 
patientstithirEtjddleft~Rntriarhrfunetioohadfewer 
myncantial~and-tres8t?yparsaulgeIyand 
repeatangbpayiilthefouow~period~in5and 
lQ-yearevent-fmcamivalratesoeartyideat#lltotbo&ia 
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Table 4. Long-Term Outcome After Percutaneous Transluminal Coronary Angioplasty 
- 
Pts With Aqiographically 
SW No. of Mean 4e MvI, successful Sunival Rate (W) 
(ref DO.), Year PI.5 w V) PICA (7) 5 Year 10 Year Comment 
Weiatroub et al. (16). 19!+4 
Hendemon et al. (IS), 1992 
Kadel et al. (19). 1992 
Taueyetal.(II),1988 
King and Schhtmpf (12), 1993 
Presm~ mkdy 
10.785 
8% 
798 
427 
169 
856 
58.3 
54.9 
52.8 
53.6 
49.5 
56.3 
29 
50 
0 
14 
42 
3f.S 
90 
81.6 
81.2 
tbl 
78.6 
82 
94 
89.2 
96 
9fl.3 
- 
90 
- 
- 
- 
- 
89.5 
78 
1980-1991; infarction exit&d: 
inten:ion to treat 
All PTC& intention to treat 
Singlevessel disease: single center; 
total caclusions excluded 
All PTCAS, single center; 
intention to treat 
411 PKAS: single center; 
intention to treat 
All FTCAx single center: 
intention to treat 
MVD = multivessel disease: PTCA = percutaneous transluminsl coronary angioplasty; Ptr = patients; ref = reference: - = not available. 
patients required repeat angiography or intervention than 
those in the surgery group (31). These findings have been 
continned by the Emory Angioplasty Versus Surgery Trial 
(EAST) (32) and the German Angioplasty Bypass Surgery 
Investigation (GABI) (33). In both studies, patients who 
underwent coronary angioplasty required significantly more 
revascularization procedures in the fohow-up period (3 years 
for EAST, 1 year for GABI), with an increased need for 
anginaI therapy, than those who underwent operation. 
Continued long-term follow-up of these groups of patients 
is essential to establish whether those assigned to coronary 
angioplasty obtain a survivaI benefit once vein graft disease 
becomes advanced, as is suggested by tbe CA.% registry data, 
thus perhaps justhying the frequent need for earIy reinterven- 
tion. 
CnneInsIuna, Long-term smvivaI in our timt 856 patients 
who underwent attempted coronary angiopIasty during the 
years 1980 to 1985 is good, partiadarIy in those patients <6B 
years old at tbe time of intervention and those with singfe- 
vessel disease and normaI left ventricular fnnction. The long 
term outcome in terms of survival and freedom from cardiac 
events was simdar in men and women and those with stable 
and unatabk angina. The majority of patients experienced a 
further cardiac evem most Iikely as a result of procedural 
failure and restenosis in the eariy follow-up period and incom- 
pletcness of rcvaaadarization and progression of atherosclero- 
sis subsequentIy. Although significant advances have occurred, 
partictdarly in improving tbe immediate success of coronary 
ang@kty ~jd in the compkxity of h&is treated, making 
comparison with current practice difficult, knowledge of 
long-term outcome remains essential in planning treatment 
strategies. 
wmary-artery stenosis: pmttatteow ~ranslumiaal coronary attgio~lasty. 
N Enal J Med 197%301:61-7. 
3. BateseER, At&run FM, Legrand V, et al. Comparative Ion-term effects of 
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